The collaboration aims to boost digital sales and customer experience in the e-mobility era BENGALURU, India, Oct. 26, 2023 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has signed a five-year collaboration with automotive marquee smart Europe GmbH to refine its Direct-to-Customer (D2C) business model… Continue reading Infosys inks five-year collaboration with smart Europe GmbH to bring sustainable electric mobility to customers
Category: Newswire
Infosys inks five-year collaboration with smart Europe GmbH to bring sustainable electric mobility to customers
The collaboration aims to boost digital sales and customer experience in the e-mobility era BENGALURU, India, Oct. 26, 2023 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has signed a five-year collaboration with automotive marquee smart Europe GmbH to refine its Direct-to-Customer (D2C) business model… Continue reading Infosys inks five-year collaboration with smart Europe GmbH to bring sustainable electric mobility to customers
RoboMarkets integruje pokročilé technologie umělé inteligence společnosti Acuity Trading a rozšiřuje tak nabídku pro klienty
LIMASSOL, Kypr, 26. října 2023 /PRNewswire/ — Evropská brokerská společnost RoboMarkets oznámila strategické partnerství se společností Acuity Trading, která je známa svými pokročilými obchodními technologiemi založenými na umělé inteligenci. Toto spojenectví zdůrazňuje závazek společnosti RoboMarkets nabízet svým retailovým i profesionálním klientům propracované alternativní pohledy na finanční trh a zajistit jim tak konkurenční výhodu v jejich… Continue reading RoboMarkets integruje pokročilé technologie umělé inteligence společnosti Acuity Trading a rozšiřuje tak nabídku pro klienty
Capital Group Finalize Transition of Long-Planned Leadership Roles
New leaders will work with other members of Capital Group’s management committee to deliver on the firm’s long-term strategy LOS ANGELES, Oct. 26, 2023 /PRNewswire/ — The Capital Group Board of Directors elected Mike Gitlin as President and Chief Executive Officer, Martin Romo as Chairman and Chief Investment Officer, and Jody Jonsson as Vice Chair of Capital… Continue reading Capital Group Finalize Transition of Long-Planned Leadership Roles
ADAMA Expands Availability of Apresa® in South America, Highly Effective Herbicide for Soybean, Corn and Other Crops
BEIJING and TEL AVIV, Israel, Oct. 26, 2023 /PRNewswire/ — ADAMA Ltd. (SZSE: 000553), a leading global crop protection company, today announced wider availability of Apresa®, a pre-emergent pre-mix herbicide that delivers broad spectrum weed control with up to 20% higher efficacy compared to tank mixed solutions. Containing two complementary modes of action at a high… Continue reading ADAMA Expands Availability of Apresa® in South America, Highly Effective Herbicide for Soybean, Corn and Other Crops
World Psoriasis Day 2023: Access for All
STOCKHOLM, Oct. 26, 2023 /PRNewswire/ — Every year on World Psoriasis Day, October 29th, the international psoriatic disease community unites to raise awareness and fight for progress. The theme of 2023, “Access for All,” underscores the vital need for Universal Health Coverage (UHC) to ensure that everyone, regardless of their location, income, or health condition,… Continue reading World Psoriasis Day 2023: Access for All
Welt-Psoriasistag 2023!: Zugang für alle
STOCKHOLM, Schweden, 26. Oktober 2023 /PRNewswire/ — Jedes Jahr vereinigt sich die internationale Gesellschaft für Psoriasis-Erkrankungen am 29. Oktober, dem Welt-Psoriasistag (engl. World Psoriasis Day), um das Bewusstsein zu schärfen und für Fortschritte zu kämpfen. Das Motto des Jahres 2023, „Zugang für alle” unterstreicht die entscheidende Notwendigkeit der Allgemeinen Gesundheitsversorgung (engl. Universal Health Coverage, UHC),… Continue reading Welt-Psoriasistag 2023!: Zugang für alle
Día Mundial de la Psoriasis 2023: Acceso para todos
ESTOCOLMO, 26 de octubre de 2023 /PRNewswire/ — Cada año, el 29 de octubre, Día Mundial de la Psoriasis, la comunidad internacional de enfermedades psoriásicas se une con el fin de generar conciencia y luchar por el progreso. El eslogan para 2023, “Acceso para todos”, destaca la necesidad vital de la cobertura sanitaria universal (CSU)… Continue reading Día Mundial de la Psoriasis 2023: Acceso para todos
Dia Mundial da Psoríase de 2023: Acesso Universal
ESTOCOLMO, 26 de outubro de 2023 /PRNewswire/ — Todos os anos, no Dia Mundial da Psoríase, comemorado em 29 de outubro, a comunidade internacional da psoríase une-se para promover a conscientização e lutar pelo progresso. O tema de 2023, “Acesso Universal”, destaca a necessidade de garantir Cobertura Universal de Saúde (CUS) para assegurar que todos,… Continue reading Dia Mundial da Psoríase de 2023: Acesso Universal
IDP Pharma announces first patient dosed in a Phase 1/2 Clinical Trial of IDP-121, a direct cMyc protein inhibitor and degrader
IDP-121 is IDP Pharma’s lead asset using its proprietary intrametics™ technology platform enabling inhibition and cellular degradation of intrinsically disordered proteins (IDPs) Targeting cMyc, a pivotal protein in tumorigenesis, is a unique opportunity in cancer therapy First patient successfully dosed in clinical Phase I/II dose escalation and expansion study in relapsed/refractory hematological malignancies BARCELONA, Spain, Oct. 26, 2023… Continue reading IDP Pharma announces first patient dosed in a Phase 1/2 Clinical Trial of IDP-121, a direct cMyc protein inhibitor and degrader